Home › Non-Small Cell Lung Cancer › NCT06945484
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Ages 18 and older at time of diagnosis * Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC) * Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery * Patient able to follow direction and complete questionnaires in English or Spanish * Patient agrees to complete the PERCC intervention Exclusion Criteria: * Morbidly obese (BMI \>40 kg/m2 ) or anorexic (BMI \<17.5 kg/m2 ) * Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance * Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer) * Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started
About the study
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
What is being tested
- Precision Exercise Regimen for Cancer Care (PERCC) (other)
Sponsor: University of Utah · Participants: 20 · Started: Nov 21, 2025
Contact the study team
- Thomas Varghese, MD, MS, MBA, FACS · Phone: 801-581-5311
- Cornelia Ulrich, MS, PhD · Phone: 801-213-5716
Official record on ClinicalTrials.gov — NCT06945484
Locations in the U.S.
| Texas | University of Texas Medical Branch at Galveston, Galveston |
| Utah | Huntsman Cancer Institute, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.